Biltmore Family Office, LLC Celularity Inc Transaction History

Biltmore Family Office, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.17 - $0.33 $1,700 - $3,300	-10,000 Reduced 2.74%	355,000 $88,000
Q1 2023 May 12, 2023	BUY	$0.56 - $1.15 $140,840 - $289,225	251,500 Added 221.59%	365,000 $226,000
Q4 2022 Feb 07, 2023	BUY	$1.08 - $2.35 $62,316 - $135,595	57,700 Added 103.41%	113,500 $146,000
Q3 2022 Nov 10, 2022	BUY	$0.43 - $4.31 $14,749 - $147,833	34,300 Added 159.53%	55,800 $129,000
Q2 2022 Aug 04, 2022	BUY	$2.81 - $12.91 $60,415 - $277,565	21,500 New	21,500 $73,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Biltmore Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Biltmore Family Office, LLC with notifications on news.